Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 04-May-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Docosanol Cream, 10% (OTC)